elliptinium has been researched along with Lung Neoplasms in 7 studies
*Lung Neoplasms: Tumors or cancer of the LUNG. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, S; el-Hamouly, W; Modi, SP; Portuese, E; Ruckdeschel, JC | 1 |
| Abele, R; Brugarolas, A; Cavalli, F; Clarysse, A; de Jager, R; Hansen, HH; Renard, G; Rozencweig, M; Siegenthaler, P | 1 |
| Atassi, G; Bisagni, E; Burbridge, M; Guilbaud, N; Jan, M; Kraus-Berthier, L; Pierré, A; Rouillon, MH; Saint-Dizier, D; Visalli, M | 1 |
| Ahomadegbe, JC; LeFevre, D; Multon, E; Riou, G; Riou, JF | 1 |
| Anderson, G; Clavel, M; Dalesio, O; Giaccone, G; Gracia, M; Kirkpatrick, A; McVie, G; Planting, AS; Smyth, J | 1 |
| Beaujean, F; Benard, J; Bettan-Renaud, L; Gavoille, A; Lopez, M; Pico, JL; Riou, G | 1 |
| Giaccone, G | 1 |
7 other study(ies) available for elliptinium and Lung Neoplasms
| Article | Year |
|---|---|
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbamates; Ellipticines; Humans; Leukemia L1210; Lung Neoplasms; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
Phase II study of 9-hydroxy-2N-methylellipticinium acetate.
Topics: Adult; Aged; Alkaloids; Antineoplastic Agents; Bone Marrow Diseases; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Drug Evaluation; Ellipticines; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms | 1984 |
In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Breast Neoplasms; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Ellipticines; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured | 1996 |
Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
Topics: Alkaloids; Amsacrine; Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Cell Line; DNA; DNA Damage; DNA Topoisomerases, Type II; Ellipticines; Humans; Lung Neoplasms; Tumor Cells, Cultured | 1989 |
Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative Group.
Topics: Adenocarcinoma; Aged; Alkaloids; Antineoplastic Agents; Carcinoma; Drug Evaluation; Ellipticines; Female; Humans; Intercalating Agents; Lung Neoplasms; Male; Middle Aged | 1989 |
In vitro chemical eradication of small cell lung cancer: application in autologous bone marrow transplantation.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Carbazoles; Carcinoma, Small Cell; Cell Line; Cell Survival; Cisplatin; Cyclophosphamide; Doxorubicin; Ellipticines; Etoposide; Humans; Intercalating Agents; Lung Neoplasms; Transplantation, Autologous; Tumor Cells, Cultured | 1988 |
The European Organization for Research and Treatment of Cancer (EORTC) trials of new agents for advanced non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Ellipticines; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitoxantrone; Nitrogen Mustard Compounds | 1988 |